Glass House Brands (GLAS) Interest & Investment Income (2020 - 2025)
Glass House Brands (GLAS) posted quarterly Interest & Investment Income of $576000.0 for Q4 2025, up 1694217.65% quarter-over-quarter from -$34.0 in Q1 2024.
Glass House Brands (GLAS) Interest & Investment Income (2020 - 2025) Analysis & Trends
Glass House Brands (GLAS) has reported Interest & Investment Income for 6 consecutive years, with $576000.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Interest & Investment Income changed N/A year-over-year to $576000.0; the TTM figure through Dec 2025 stood at $35.7 million (changed N/A YoY), while the FY2025 annual figure was $288000.0, changed N/A from the prior year.
- Interest & Investment Income rose to $576000.0 in Q4 2025 per GLAS's latest filing, from -$34.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $35.1 million in Q4 2023 and bottomed at -$32.2 billion in Q2 2021.
- Historically, Interest & Investment Income has averaged -$3.8 billion across 5 years, with a median of -$34.0 in 2023.
- Annual changes were most pronounced in 2023 — Interest & Investment Income soared 61488.48% — and 2024, when it plunged 100.04%.
- Glass House Brands' Interest & Investment Income stood at $113502.0 in 2021, then tumbled by 49.8% to $56975.0 in 2022, then jumped by 61488.48% to $35.1 million in 2023, then plunged by 100.0% to -$34.0 in 2024, then surged by 1694217.65% to $576000.0 in 2025.
- Business Quant data shows GLAS's Interest & Investment Income at $576000.0 in Q4 2025, -$34.0 in Q1 2024, and $35.1 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.81 Bn | 42.84 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.29 Bn | 39.63 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.59 Bn | 29.91 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.88 Bn | 5.10 Bn | 154.39 Mn |
| 5 | United Therapeutics | 22.24 Bn | 19.58 Bn | 683.80 Mn | 31.50 Mn |
| 6 | Viatris | 18.79 Bn | 17.91 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.71 Bn | 15.32 Bn | 935.80 Mn | 12.40 Mn |
| 8 | Elanco Animal Health | 12.09 Bn | 11.56 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Glass House Brands | 840.76 Mn | 822.21 Mn | 15.77 Mn | -470,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 576,000.00 |
| Mar 31, 2024 | -34.00 |
| Dec 31, 2023 | 35.09 Mn |
| Sep 30, 2023 | -34.00 |
| Jun 30, 2023 | -35.00 Mn |
| Mar 31, 2023 | 85,748.00 |
| Dec 31, 2022 | 56,975.00 |
| Sep 30, 2022 | -35.00 |
| Jun 30, 2022 | -472.00 Mn |
| Dec 31, 2021 | 113,502.00 |
| Sep 30, 2021 | -16.44 Bn |
| Jun 30, 2021 | -32.22 Bn |
| Mar 31, 2021 | -16,086.00 |
| Mar 31, 2020 | -98,341.00 |